PURINETHOL (mercaptopurine) is indicated for maintenance therapy of acute lymphatic (lymphocytic, lymphoblastic) leukemia as part of a combination regimen. The response to this agent depends upon the particular subclassification of acute lymphatic leukemia and the age of the patient (pediatric or adult)...
Mercaptopurine is not effective for prophylaxis or treatment of central nervous system leukemia.
Also known as: www.purinethol.com